Recruiting
Chronic kidney disease+1
RecruitingA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
Investigational
A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
Investigational
- Disease:Chronic kidney diseaseArteriosclerosis
- Substances:–
Countries:
United States
United States- Participants:18–64 years · 65+ years
- Sponsor:Eli Lilly & Co.



